• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜癌指数分布对接受细胞减灭术和腹腔内热灌注化疗患者的影响。

Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

作者信息

Wong Jolene Si Min, Tan Grace Hwei Ching, Cheok Sabrina Hui Xian, Ong Chin-Ann Johnny, Chia Claramae Shulyn, Teo Melissa Ching Ching

机构信息

Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.

Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, Singapore General Hospital, Singapore, Singapore.

出版信息

Pleura Peritoneum. 2022 Apr 26;7(2):95-102. doi: 10.1515/pp-2021-0150. eCollection 2022 Jun 1.

DOI:10.1515/pp-2021-0150
PMID:35812008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9166179/
Abstract

OBJECTIVES

Peritoneal cancer index (PCI) score is a common prognostication tool in peritoneal metastases (PM). We hypothesize that the distribution of PCI score and involvement of specific regions affects survival and morbidity outcomes.

METHODS

Data was collected from a prospective database of patients who underwent CRS and HIPEC for PM at the National Cancer Centre Singapore. We evaluate the relationship between PCI, PCI distribution, and survival and morbidity outcomes.

RESULTS

One hundred and fifty-two patients underwent CRS and HIPEC with a median PCI score of nine (range 0-31). Median overall survival (OS) and progression free survival (PFS) were 43 and 17 months, respectively. Region six (pelvis) was most commonly involved and had the highest frequency of heavy disease burden. Presence of PM in the lower abdomen, flanks, and small bowel were associated with poorer OS (p=0.01, 0.03, <0.001) and PFS (p=0.04, 0.02, <0.001). Involvement of porta hepatitis predicted poorer OS but not PFS (p=0.03). Involvement of the gastric antrum resulted in higher rates of postoperative complications.

CONCLUSIONS

The pattern of PCI distribution may be associated with varying survival and morbidity outcomes.

摘要

目的

腹膜癌指数(PCI)评分是腹膜转移(PM)中常用的预后评估工具。我们假设PCI评分的分布及特定区域的受累情况会影响生存和发病结局。

方法

数据收集自新加坡国立癌症中心接受CRS和HIPEC治疗PM患者的前瞻性数据库。我们评估PCI、PCI分布与生存和发病结局之间的关系。

结果

152例患者接受了CRS和HIPEC治疗,PCI评分中位数为9(范围0 - 31)。总生存(OS)和无进展生存(PFS)的中位数分别为43个月和17个月。区域六(骨盆)最常受累,且疾病负担重的频率最高。下腹部、侧腹和小肠存在PM与较差的OS(p = 0.01、0.03、<0.001)和PFS(p = 0.04、0.02、<0.001)相关。肝门受累预示较差的OS,但不影响PFS(p = 0.03)。胃窦受累导致术后并发症发生率更高。

结论

PCI分布模式可能与不同的生存和发病结局相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/e88fd67ad9a9/j_pp-2021-0150_fig_005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/290005fc37a8/j_pp-2021-0150_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/657c91c60ac6/j_pp-2021-0150_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/e67d2354a318/j_pp-2021-0150_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/9315e14095ee/j_pp-2021-0150_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/e88fd67ad9a9/j_pp-2021-0150_fig_005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/290005fc37a8/j_pp-2021-0150_fig_001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/657c91c60ac6/j_pp-2021-0150_fig_002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/e67d2354a318/j_pp-2021-0150_fig_003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/9315e14095ee/j_pp-2021-0150_fig_004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d843/9166179/e88fd67ad9a9/j_pp-2021-0150_fig_005.jpg

相似文献

1
Implications of peritoneal cancer index distribution on patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.腹膜癌指数分布对接受细胞减灭术和腹腔内热灌注化疗患者的影响。
Pleura Peritoneum. 2022 Apr 26;7(2):95-102. doi: 10.1515/pp-2021-0150. eCollection 2022 Jun 1.
2
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.基于腹膜癌指数(PCI)的患者选择策略用于胃癌伴腹膜转移行完全细胞减灭术加腹腔热灌注化疗:一项单中心回顾性分析 125 例患者。
Eur J Surg Oncol. 2021 Jun;47(6):1411-1419. doi: 10.1016/j.ejso.2020.11.139. Epub 2020 Dec 1.
3
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.结直肠腹膜转移且腹膜肿瘤指数较高的患者可能从细胞减灭术和腹腔热灌注化疗中获益。
Eur J Surg Oncol. 2020 Dec;46(12):2283-2291. doi: 10.1016/j.ejso.2020.07.039. Epub 2020 Aug 5.
4
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].1384例腹膜癌病患者接受细胞减灭术加腹腔内热灌注化疗的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
5
Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.胃癌腹膜转移患者在诱导化疗有反应后行腹腔热灌注化疗手术。
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S47-S56. doi: 10.21037/jgo-20-121.
6
Novel prognostic score for outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with metachronous peritoneal carcinomatosis.结直肠癌伴异时性腹膜转移患者细胞减灭术和腹腔热灌注化疗后结局的新型预后评分。
ANZ J Surg. 2020 Oct;90(10):1958-1964. doi: 10.1111/ans.15783. Epub 2020 Mar 11.
7
Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.小肠腺癌细胞减灭术及热灌注化疗后的复发与生存结果
Anticancer Res. 2017 Oct;37(10):5737-5742. doi: 10.21873/anticanres.12012.
8
Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate.细胞减灭术和腹腔内热化疗治疗结直肠腹膜转移:大容量疾病和治愈率的队列分析。
J Surg Oncol. 2014 Aug;110(2):203-6. doi: 10.1002/jso.23610. Epub 2014 May 21.
9
Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.新辅助化疗联合腹腔热灌注化疗治疗结直肠腹膜转移患者的安全性和有效性:一项回顾性研究。
World J Surg Oncol. 2021 May 17;19(1):151. doi: 10.1186/s12957-021-02255-w.
10
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.结直肠和阑尾腹膜转移的细胞减灭术和腹腔热灌注化疗(HIPEC)-香港经验和文献复习。
Asian J Surg. 2021 Jan;44(1):221-228. doi: 10.1016/j.asjsur.2020.05.010. Epub 2020 Jun 27.

引用本文的文献

1
Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines.美国镭学会关于不同肿瘤起源的腹膜癌病管理的合理使用标准:系统评价与指南执行摘要
Cancer Med. 2025 Jul;14(14):e71043. doi: 10.1002/cam4.71043.
2
Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments.转化性热灌注化疗:利用计算机模拟改善热灌注化疗治疗效果
J Gastrointest Oncol. 2024 Dec 31;15(6):2745-2747. doi: 10.21037/jgo-24-755. Epub 2024 Dec 18.
3
Intra-abdominal temperature variation during hyperthermic intraperitoneal chemotherapy evaluated via computational fluid dynamics modeling.

本文引用的文献

1
Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases.中低收入国家腹膜表面恶性肿瘤的细胞减灭术和 HIPEC 的可行性和结果:单中心 232 例经验。
World J Surg Oncol. 2021 Jun 5;19(1):164. doi: 10.1186/s12957-021-02276-5.
2
Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.新辅助化疗联合腹腔热灌注化疗治疗结直肠腹膜转移患者的安全性和有效性:一项回顾性研究。
World J Surg Oncol. 2021 May 17;19(1):151. doi: 10.1186/s12957-021-02255-w.
3
通过计算流体动力学建模评估热腹腔内化疗期间的腹腔内温度变化。
J Gastrointest Oncol. 2024 Aug 31;15(4):1847-1860. doi: 10.21037/jgo-24-352. Epub 2024 Aug 28.
4
Evaluating geographical disparities on clinical outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.评估细胞减灭术和腹腔内热灌注化疗后临床结局的地理差异。
Tech Coloproctol. 2024 Feb 20;28(1):35. doi: 10.1007/s10151-024-02911-9.
Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma.
关于 CT 特征预测恶性腹膜间皮瘤患者治疗结局。
Eur J Surg Oncol. 2021 Sep;47(9):2212-2219. doi: 10.1016/j.ejso.2021.04.012. Epub 2021 Apr 14.
4
Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer.术中腹腔内化疗对结直肠癌患者的疗效及安全性
World J Surg Oncol. 2021 Mar 22;19(1):84. doi: 10.1186/s12957-021-02197-3.
5
Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index.针对腹膜癌指数高的腹膜假黏液瘤的两步减瘤手术及腹腔热灌注化疗
World J Surg Oncol. 2021 Feb 23;19(1):60. doi: 10.1186/s12957-021-02171-z.
6
Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.对于接受减瘤手术及腹腔热灌注化疗治疗腹膜癌病的患者,术后C反应蛋白动力学可预测术后并发症。
World J Surg Oncol. 2020 Nov 26;18(1):311. doi: 10.1186/s12957-020-02081-6.
7
Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites.腹腔热灌注化疗(HIPEC)治疗恶性腹水的疗效。
World J Surg Oncol. 2020 Jul 22;18(1):180. doi: 10.1186/s12957-020-01956-y.
8
The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.同步性在结直肠腹膜转移的细胞减灭术和腹腔热灌注化疗中的重要性。
World J Surg Oncol. 2020 Jan 13;18(1):10. doi: 10.1186/s12957-020-1784-4.
9
CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival.结直肠癌继发腹膜转移患者的CRS和HIPEC:小肠PCI评分作为生存预测指标
Pleura Peritoneum. 2019 Oct 30;4(4):20190018. doi: 10.1515/pp-2019-0018. eCollection 2019 Dec 1.
10
Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.行细胞减灭术和腹腔内化疗治疗下消化道恶性肿瘤患者胃切除术的短期和长期结果:倾向评分匹配分析。
Ann Surg Oncol. 2019 Oct;26(11):3627-3635. doi: 10.1245/s10434-019-07510-9. Epub 2019 Jul 10.